Literature DB >> 24080087

Aldehyde dehydrogenase-1a1 induces oncogene suppressor genes in B cell populations.

R Yasmeen1, J M Meyers1, C E Alvarez2, J L Thomas1, A Bonnegarde-Bernard3, H Alder4, T L Papenfuss3, D M Benson5, P N Boyaka3, O Ziouzenkova6.   

Abstract

The deregulation of B cell differentiation has been shown to contribute to autoimmune disorders, hematological cancers, and aging. We provide evidence that the retinoic acid-producing enzyme aldehyde dehydrogenase 1a1 (Aldh1a1) is an oncogene suppressor in specific splenic IgG1(+)/CD19(-) and IgG1(+)/CD19(+) B cell populations. Aldh1a1 regulated transcription factors during B cell differentiation in a sequential manner: 1) retinoic acid receptor alpha (Rara) in IgG1(+)/CD19(-) and 2) zinc finger protein Zfp423 and peroxisome proliferator-activated receptor gamma (Pparg) in IgG1(+)/CD19(+) splenocytes. In Aldh1a1(-/-) mice, splenic IgG1(+)/CD19(-) and IgG1(+)/CD19(+) B cells acquired expression of proto-oncogenic genes c-Fos, c-Jun, and Hoxa10 that resulted in splenomegaly. Human multiple myeloma B cell lines also lack Aldh1a1 expression; however, ectopic Aldh1a1 expression rescued Rara and Znf423 expressions in these cells. Our data highlight a mechanism by which an enzyme involved in vitamin A metabolism can improve B cell resistance to oncogenesis.
© 2013.

Entities:  

Keywords:  AP1; Aldh1a1; Homeobox transcription factor; Hoxa10; Ig; Multiple myeloma; Nuclear receptor; Pparg; RA; RARE; Raldh1; Rara; Retinaldehyde; Vitamin A metabolism; Zfp423; Znf423; activator protein 1 a heterodimeric transcription factor formed by c-jun and c-fos; aldehyde dehydrogenase 1a1; c-Fos; c-Jun; human zinc finger protein; immunoglobulin; murine zinc finger protein; peroxisome proliferator-activated receptor; protein encoded by c-Jun gene; retinoic acid; retinoic acid receptor alpha; retinoic acid receptor response element; transcription factor encoded by the FOS gene; transcription factor homeobox protein a10

Mesh:

Substances:

Year:  2013        PMID: 24080087      PMCID: PMC3853404          DOI: 10.1016/j.bbamcr.2013.09.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  47 in total

1.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

Authors:  Fenghuang Zhan; Johanna Hardin; Bob Kordsmeier; Klaus Bumm; Mingzhong Zheng; Erming Tian; Ralph Sanderson; Yang Yang; Carla Wilson; Maurizio Zangari; Elias Anaissie; Christopher Morris; Firas Muwalla; Frits van Rhee; Athanasios Fassas; John Crowley; Guido Tricot; Bart Barlogie; John Shaughnessy
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  IgG2a and igA co-expression by the natural autoantibody-producing murine B lymphoma T560.

Authors:  J M Phillips-Quagliata; A M Faria; J Han; D H Spencer; G Haughton; P Casali
Journal:  Autoimmunity       Date:  2001-05       Impact factor: 2.815

3.  Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism.

Authors:  Yun Dai; Terry H Landowski; Steven T Rosen; Paul Dent; Steven Grant
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Authors:  Gunhild Trøen; Vigdis Nygaard; Tor-Kristian Jenssen; Ida Münster Ikonomou; Anne Tierens; Estella Matutes; Alicja Gruszka-Westwood; Daniel Catovsky; Ola Myklebost; Grete Lauritzsen; Eivind Hovig; Jan Delabie
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

5.  Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).

Authors:  D Donjerković; C M Mueller; D W Scott
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

6.  Contrasting impairments in IgM and IgG responses of vitamin A-deficient mice.

Authors:  S M Smith; C E Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Nutritional factors and autoimmunity. IV. Dietary vitamin A deprivation induces a selective increase in IgM autoantibodies and hypergammaglobulinemia in New Zealand Black mice.

Authors:  M E Gershwin; D R Lentz; R S Beach; L S Hurley
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element.

Authors:  Mathias François; Pascal Richette; Lydia Tsagris; Michel Raymondjean; Marie-Claude Fulchignoni-Lataud; Claude Forest; Jean-François Savouret; Marie-Thérèse Corvol
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

9.  Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina.

Authors:  Xiaohong Fan; Andrei Molotkov; Shin-Ichi Manabe; Christine M Donmoyer; Louise Deltour; Mario H Foglio; Arnold E Cuenca; William S Blaner; Stuart A Lipton; Gregg Duester
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  The effect of at-birth vitamin A supplementation on differential leucocyte counts and in vitro cytokine production: an immunological study nested within a randomised trial in Guinea-Bissau.

Authors:  Mathias J Jørgensen; Ane B Fisker; Erliyani Sartono; Andreas Andersen; Christian Erikstrup; Ida M Lisse; Maria Yazdanbakhsh; Peter Aaby; Christine S Benn
Journal:  Br J Nutr       Date:  2012-07-11       Impact factor: 3.718

View more
  9 in total

Review 1.  ZNF423: Transcriptional modulation in development and cancer.

Authors:  Lena Harder; Ann-Christin Puller; Martin A Horstmann
Journal:  Mol Cell Oncol       Date:  2014-12-23

2.  Retinoic acid signaling determines the fate of uterine stroma in the mouse Müllerian duct.

Authors:  Tadaaki Nakajima; Taisen Iguchi; Tomomi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-22       Impact factor: 11.205

Review 3.  Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Authors:  Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

4.  Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.

Authors:  Andrew D Snyder; Sharon D Ochs; Brooke E Johnson; Courtney E W Sulentic
Journal:  Mol Immunol       Date:  2020-03-06       Impact factor: 4.407

5.  Inflammation rapidly modulates the expression of ALDH1A1 (RALDH1) and vimentin in the liver and hepatic macrophages of rats in vivo.

Authors:  Kyoko Ito; Reza Zolfaghari; Lei Hao; A Catharine Ross
Journal:  Nutr Metab (Lond)       Date:  2014-11-25       Impact factor: 4.169

6.  Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.

Authors:  Richard Ahn; Rashmi Gupta; Kevin Lai; Nitin Chopra; Sarah T Arron; Wilson Liao
Journal:  BMC Genomics       Date:  2016-10-28       Impact factor: 3.969

Review 7.  Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?

Authors:  Jennifer M Petrosino; David Disilvestro; Ouliana Ziouzenkova
Journal:  Nutrients       Date:  2014-03-03       Impact factor: 5.717

8.  Chromothripsis in Treatment Resistance in Multiple Myeloma.

Authors:  Kyoung Joo Lee; Ki Hong Lee; Kyong-Ah Yoon; Ji Yeon Sohn; Eunyoung Lee; Hyewon Lee; Hyeon-Seok Eom; Sun-Young Kong
Journal:  Genomics Inform       Date:  2017-09-28

9.  Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin.

Authors:  Aejin Lee; McKensie L Mason; Tao Lin; Shashi Bhushan Kumar; Devan Kowdley; Jacob H Leung; Danah Muhanna; Yuan Sun; Joana Ortega-Anaya; Lianbo Yu; Julie Fitzgerald; A Courtney DeVries; Randy J Nelson; Zachary M Weil; Rafael Jiménez-Flores; Jon R Parquette; Ouliana Ziouzenkova
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.